Notice2023-05177
Office of the Secretary, Muscular Dystrophy Coordinating Committee Call for Committee Membership Nominations
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
March 14, 2023
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Abstract
The Office of the Secretary of the Department of Health and Human Services (HHS) is seeking nominations for three individuals to serve as non-federal public members on the Muscular Dystrophy Coordinating Committee.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 49 (Tuesday, March 14, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 49 (Tuesday, March 14, 2023)]
[Notices]
[Pages 15730-15731]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-05177]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Secretary, Muscular Dystrophy Coordinating
Committee Call for Committee Membership Nominations
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Office of the Secretary of the Department of Health and
Human Services (HHS) is seeking nominations for three individuals to
serve as non-federal public members on the Muscular Dystrophy
Coordinating Committee.
DATES: Nominations are due by 5 p.m. EDT on April 28, 2023.
ADDRESSES: Nominations must be sent to Glen Nuckolls, Ph.D., by email
to <a href="/cdn-cgi/l/email-protection#69071c0a020605050e290700070d1a47070001470e061f"><span class="__cf_email__" data-cfemail="2a445f49414546464d6a4443444e5904444342044d455c">[email protected]</span></a>.
FOR FURTHER INFORMATION CONTACT: Glen Nuckolls, Ph.D., by email to
<a href="/cdn-cgi/l/email-protection#6b051e08000407070c2b0502050f1845050203450c041d"><span class="__cf_email__" data-cfemail="bfd1cadcd4d0d3d3d8ffd1d6d1dbcc91d1d6d791d8d0c9">[email protected]</span></a> or (301) 496-5745.
SUPPLEMENTARY INFORMATION: The Muscular Dystrophy Coordinating
Committee (MDCC) is a federal advisory committee established in
accordance with the Muscular Dystrophy Community Assistance, Research,
and Education Amendments of 2001 (MD-CARE Act; Pub. L. 107-84). The MD-
CARE Act was reauthorized in 2008 by Public Law 110-361, and again in
2014 by Public Law 113-166. The MD-CARE Act specifies that the
committee membership be composed of \2/3\ governmental agency
representatives and \1/3\ public members. We are seeking nominations
for three non-federal public members at this time, due to turnover of
committee membership. Nominations will be accepted until 5:00 p.m. EDT
on April 28, 2023.
Who is Eligible: Nominations are encouraged for new or
reappointment of non-federal public members who can provide the public
and/or patient perspectives to discussions of issues considered by the
Committee. Self-nominations and nominations of other
[[Page 15731]]
individuals are both permitted. Only one nomination per individual is
required. Multiple nominations for the same individual will not
increase likelihood of selection. Non-federal public members may be
selected from the pool of submitted nominations or other sources as
needed to meet statutory requirements and to form a balanced committee
that represents the diversity within the muscular dystrophy
communities. Nominations are especially encouraged from leaders or
representatives of muscular dystrophy research, advocacy, or service
organizations, as well as individuals with muscular dystrophy or their
parents or guardians. In accordance with White House Office of
Management and Budget guidelines (FR Doc. 2014-19140), federally-
registered lobbyists are not eligible.
Committee Composition: The Department strives to ensure that the
membership of HHS Federal advisory committees is fairly balanced in
terms of points of view represented and the committee's function. Every
effort is made to ensure that the views of all genders, all ethnic and
racial groups, and people with disabilities are represented on HHS
Federal advisory committees and, therefore, the Department encourages
nominations of qualified candidates from these groups. The Department
also encourages geographic diversity in the composition of the
Committee. Appointment to this Committee shall be made without
discrimination on the basis of age, race, ethnicity, gender, sexual
orientation, disability, and cultural, religious, or socioeconomic
status. Requests for reasonable accommodation to enable participation
on the Committee should be indicated in the nomination submission.
Member Terms: Non-Federal public members of the Committee serve for
a term of three years and may serve for an unlimited number of terms if
reappointed. Members may serve after the expiration of their terms,
until their successors have taken office.
Meetings and Travel: As specified by Public Law 113-166, the MDCC
``shall meet no fewer than two times per calendar year.'' Travel
expenses are provided for non-federal public Committee members to
facilitate attendance at in-person meetings. Members are expected to
make every effort to attend all full committee meetings, twice per
year, either in person or via remote access. Participation in relevant
subcommittee, working and planning group meetings, and workshops, is
also encouraged.
Submission Instructions and Deadline: Nominations are due by 5:00
p.m. EDT on April 28, 2023, and should be sent to Glen Nuckolls, Ph.D.,
by email to <a href="/cdn-cgi/l/email-protection#7e100b1d15111212193e1017101a0d5010171650191108"><span class="__cf_email__" data-cfemail="6a041f09010506060d2a0403040e1944040302440d051c">[email protected]</span></a>.
Nominations must include contact information for the nominee, a
current curriculum vitae or resume of the nominee, and a paragraph
describing the qualifications of the person to represent some
portion(s) of the muscular dystrophy research, advocacy, and/or patient
care communities.
More information about the MDCC is available at <a href="https://mdcc.nih.gov/">https://mdcc.nih.gov/</a>.
Dated: March 8, 2023.
Walter J. Koroshetz,
Director, National Institute of Neurological Disorders and Stroke,
National Institutes of Health.
[FR Doc. 2023-05177 Filed 3-13-23; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on March 14, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.